Home > Income Statement > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Consolidated Net Profit

    Back to Income Statement
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results

GLENMARK LIFE SCIENCES Last 5 Year Consolidated Net Profit History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹467 Cr₹419 Cr₹352 Cr₹313 Cr₹196 Cr

What is the latest Consolidated Net Profit of GLENMARK LIFE SCIENCES ?

The latest Consolidated Net Profit ratio of GLENMARK LIFE SCIENCES is ₹467 Cr based on Mar2023 Standalone results.
Year Consolidated Net Profit
Mar2023₹467 Cr
Mar2022₹419 Cr
Mar2021₹352 Cr
Mar2020₹313 Cr
Mar2019₹196 Cr

How is Consolidated Net Profit of GLENMARK LIFE SCIENCES Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹467 Cr
11.52
Mar2022 ₹419 Cr
19.10
Mar2021 ₹352 Cr
12.29
Mar2020 ₹313 Cr
60.08
Mar2019 ₹196 Cr -

Compare Consolidated Net Profit of peers of GLENMARK LIFE SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES ₹10,156.5 Cr 0.4% 7% 75.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


GLENMARK LIFE SCIENCES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES

0.4%

7%

75.9%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses